http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6131631

Outgoing Links

Predicate Object
contentType Journal Article|Research Support, Non-U.S. Gov't
endingPage 5670
issn 1865-8652
0741-238X
issueIdentifier 12
pageRange 5662-5670
publicationName Advances in Therapy
startingPage 5662
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1aed2c099147eb85cf5532507022f640
bibliographicCitation Liao W, Lei W, Feng M, Yang Y, Wu Q, Zhou K, Bai L, Wen F, Li Q. Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States. Adv Ther. 2021 Dec;38(12):5662–70. doi: 10.1007/s12325-021-01926-0. PMID: 34664194.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_175c42e5ab145cae383f5f0d2f961f81
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a3b61364042b8089d0cb0b0a6ee3b94d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_521c80ac4889bd59a2d6ff8f446ff1d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f01fe7998c3b754ca06047a7f1cf76a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cca8e82f65be5fc92189440966a94c2a
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cc8272c9d1d99a5f65b7f40f242ab98c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_02fef4622449bdc87307ff1f90a0209b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ab0a0218f59aac53db36f244901d2091
date 2021-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/34664194
https://doi.org/10.1007/s12325-021-01926-0
isPartOf https://portal.issn.org/resource/ISSN/1865-8652
https://portal.issn.org/resource/ISSN/0741-238X
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2011
language English
source https://www.crossref.org/
https://scigraph.springernature.com/
https://pubmed.ncbi.nlm.nih.gov/
title Cost-Effectiveness Analysis of First-Line Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma in the United States
discusses http://id.nlm.nih.gov/mesh/M0018233
http://id.nlm.nih.gov/mesh/M0001214
http://id.nlm.nih.gov/mesh/M0585694
http://id.nlm.nih.gov/mesh/M0558240
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25102847
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5329102
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7170

Total number of triples: 37.